Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nutrition 21

This article was originally published in The Tan Sheet

Executive Summary

Obtains exclusive patent rights for use of chromium to relieve symptoms of depression and premenstrual syndrome (U.S. Patent Nos. 6,034,125 and 5,972,390, respectively) when administered at doses ranging from 200 mcg to 500 mcg, Chromax manufacturer announces May 24. Ingredient supplier also is sponsoring upcoming study at Duke University Medical Center, led by Professor of Psychiatry Jonathan Davidson, MD, to further substantiate chromium picolinate's beneficial effects on depression
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS092626

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel